Ortin Laboratories Ltd - Stock Valuation and Financial Performance

BSE: 539287 | NSE: ORTINLAB | Pharmaceuticals & Drugs | Small Cap

Ortin Laboratories Share Price

17.80 0.83 4.89%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Ortin Laboratories

M-Cap below 100cr DeciZen not available

Ortin Laboratories stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
14.5 Cr.
52-wk low:
16.2
52-wk high:
30.3

Is Ortin Laboratories Ltd an attractive stock to invest in?

1. Is Ortin Laboratories Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Ortin Laboratories Ltd is a below average quality company.

2. Is Ortin Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Ortin Laboratories Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Ortin Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Ortin Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Ortin Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Ortin Laboratories Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 9.5%8%7.3%5.8%7.3%8.2%3.9%5.1%0.9%1.2%-
Value Creation
Index
-0.3-0.4-0.5-0.6-0.5-0.4-0.7-0.6-0.9-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 67.160.462.966.879.71681978.28.263
Sales YoY Gr.--10%4.2%6.1%19.4%110.5%17.7%-95.9%0.7%-26.9%-
Adj EPS 0.70.50.50.20.30.8-0.31.2-0.5-0.1-5
YoY Gr.--24.3%-9.4%-50%37.5%127.3%-142.7%NA-142.2%NA-
BVPS (₹) 1313.313.713.814.214.814.11413.513.48.6
Adj Net
Profit
1.20.90.80.40.61.3-0.61-0.4-0.1-4
Cash Flow from Ops. -1.8-1.40.51.91.66.53.3182.2-0.3-
Debt/CF from Ops. -10.6-15.240.48.911.135.90.42.9-25.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -23.5%-40.4%-68.8%-26.9%
Adj EPS -179.6%-177.1%NANA
BVPS0.3%-1.2%-1.7%-0.8%
Share Price 5.2% 4.8% -16.8% -0.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
5.54.13.51.82.45.2-2.25.4-3.6-0.7-45.7
Op. Profit
Mgn %
9.110.49.486.93.72.915.34.68.7-100.7
Net Profit
Mgn %
1.81.51.30.60.70.8-0.311.6-4.8-1.2-119.1
Debt to
Equity
0.90.90.90.70.70.80.80.60.60.6-
Working Cap
Days
2392592352232051441592,175261364423
Cash Conv.
Cycle
50851171271186151263182256-166

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 0.59

Return on Equity is Poor

Sales growth has been subdued in last 3 years -68.76%

Sales growth is not so good in last 4 quarters at -57.84%

Latest Financials - Ortin Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) -5 -
TTM Sales (₹ Cr.) 3.4 -
BVPS (₹.) 8.6 -
Reserves (₹ Cr.) -1 -
P/BV 2.08 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 16.15 / 30.33
All Time Low / High (₹) 6.60 / 52.25
Market Cap (₹ Cr.) 14.5
Equity (₹ Cr.) 8.1
Face Value (₹) 10
Industry PE 48.2

Management X-Ray of Ortin Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Ortin Laboratories

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales67.1460.4162.9466.7579.71167.76197.398.178.236.02
Operating Expenses 61.0554.1457.0561.4074.31161.52191.716.927.865.50
Manufacturing Costs7.387.6210.239.449.5418.2126.570.510.520.39
Material Costs48.6641.7241.3345.5957.59134.82154.623.954.653.39
Employee Cost 1.791.742.132.592.783.684.720.850.740.68
Other Costs 3.213.073.373.784.394.825.801.611.951.04
Operating Profit 6.096.285.895.355.406.245.681.250.380.52
Operating Profit Margin (%) 9.1%10.4%9.4%8.0%6.8%3.7%2.9%15.2%4.6%8.6%
Other Income 0.810.220.570.420.450.570.200.050.190.04
Interest 3.723.523.422.943.493.223.210.870.810.40
Depreciation 1.511.641.651.701.691.751.960.290.290.25
Exceptional Items 000000000-0.03
Profit Before Tax 1.681.331.401.130.681.840.720.14-0.53-0.11
Tax 0.500.440.560.6300.561.28-0.81-0.13-0.02
Profit After Tax 1.190.900.830.500.681.28-0.560.95-0.40-0.09
PAT Margin (%) 1.8%1.5%1.3%0.8%0.9%0.8%-0.3%11.6%-4.8%-1.6%
Adjusted EPS (₹)0.70.50.50.30.40.8-0.31.2-0.5-0.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 21.9622.4423.2723.4024.0825.0923.8211.3610.9610.86
Share Capital 16.9416.9416.9416.9416.9416.9416.948.138.138.13
Reserves 5.025.506.336.467.148.156.883.222.832.73
Minority Interest0000000000
Debt18.0219.7520.0216.5416.1419.4719.576.946.146.45
Long Term Debt2.804.954.801.421.484.744.901.441.732.96
Short Term Debt15.2214.8015.2215.1214.6614.7414.675.504.423.48
Trade Payables26.3916.852.817.0516.5847.60601.340.791.55
Others Liabilities 6.508.7119.7114.5416.8612.9213.131.632.822.34
Total Liabilities 72.8767.7565.8261.5373.66105.09116.5221.2720.7021.20

Fixed Assets

Gross Block31.7731.5832.9322.3523.3126.3229.4418.9119.0418.78
Accumulated Depreciation7.879.7511.301.673.285.036.994.544.834.82
Net Fixed Assets23.9021.8321.6320.6920.0321.2922.4514.3814.2113.96
CWIP 0000.350.400.530.430.430.430.43
Investments 0.030.030.030.070.080.080.07000
Inventories21.7221.9816.8417.6524.0236.9649.901.831.742.60
Trade Receivables21.4217.149.1315.2421.8537.8337.153.913.243.42
Cash Equivalents 1.161.741.661.431.692.142.500.180.600.26
Others Assets4.635.0316.536.105.596.254.020.540.490.54
Total Assets 72.8767.7565.8261.5373.66105.09116.5221.2720.7021.20

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity -1.76-1.380.521.941.566.523.3018.032.15-0.25
PBT 1.731.331.401.130.681.840.720.14-0.53-0.11
Adjustment 4.644.964.491.691.395.215.411.161.100.64
Changes in Working Capital -4.03-3.66-1.46-0.260.06-0.1-1.9916.741.58-0.78
Tax Paid -0.38-0.49-0.50-0.62-0.58-0.42-0.83000
Cash Flow From Investing Activity -0.030.22-0.86-1.26-0.90-3.27-3.090.07-0.130.01
Capex -0.630-1.44-0.76-0.74-3.01-3.120-0.130.01
Net Investments 000-0.01-0.01-0.01-0.080.0700
Others 0.600.220.57-0.49-0.15-0.250.10000
Cash Flow From Financing Activity 0.971.730.27-0.820.07-2.89-1.33-9.86-0.470.90
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0.971.730.27-0.820.070.333.09-3.4600
Interest Paid 00000-3.22-3.21-0.87-0.81-0.40
Dividend Paid 0000000000
Others 000000-1.21-5.520.341.30
Net Cash Flow -0.810.58-0.07-0.140.730.37-1.128.251.550.66
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)5.554.043.652.162.865.21-2.315.38-3.57-0.86
ROCE (%)13.6211.5511.019.5810.1411.768.933.271.561.66
Asset Turnover Ratio0.980.921.011.051.191.881.780.120.390.29
PAT to CFO Conversion(x)-1.48-1.530.633.882.295.09N/A18.98N/AN/A
Working Capital Days
Receivable Days1241097167846569918159202
Inventory Days94123105949466801,15679132
Payable Days210189873975871272,83483126

Ortin Laboratories Ltd Stock News

Ortin Laboratories Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Ortin Laboratories on 28-Mar-2024 16:01 is ₹17.80.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Ortin Laboratories stood at ₹14.47.
The latest P/E ratio of Ortin Laboratories as of 28-Mar-2024 16:01 is 0.00.
The latest P/B ratio of Ortin Laboratories as of 28-Mar-2024 16:01 is 2.08.
The 52-week high of Ortin Laboratories is ₹30.33 and the 52-week low is ₹16.15.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ortin Laboratories is ₹3.42 ( Cr.) .

About Ortin Laboratories Ltd

Ortin Laboratories established in the year 1986  was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public. These proceeds were utilised for constructing a factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of Tablets, Capsules, Syrups, Dry Powders & Ointments. Due to its concern for quality, the company stands as a leading and predominant pharmaceutical manufacturer of drugs and medicines of the country with turnover running in crores of rupees.

Quality is the hallmark of Ortin. At every stage of production from raw material to finished products, highest standard of quality is ensured with the help of most modern equipment and experienced personnel.This unflinching perseverance towards quality has helped the company to earn enormous goodwill & trust, both from medical profession and pharmaceutical trade.

Being in partnership with the world means respecting its resources without compromise and so at Ortin, continuous process evaluation and monitoring waste recoveries ensure that the focus is maintained. Specialized facilities have helped us to earn a reputation for the expert handling of hazardous materials in the form of reactants and products. Teams from the ministry of health regularly inspect the company's plant. Every care is taken for treatment of solid wasters, discharged liquids and atmospheric releases.

Ortin is contemplating an entry into the OTC segment as part of its long term growth strategy. It is channeling its efforts towards building an overseas marketing network in order to enhance exports to third world countries. Ortin proposes to be certified as a WHO GMP Unit and to launch innovative Biotechnology products in Orthopedic and Dental Segments. The success behind them is only the Reliance which they carry for their Quality from the people all over the country. Their motto, right from their inception has been towards Quality and they still maintain them and continue to do so in future.

Products manufactured by the company include:

  • Capsules
  • Syrups / Dry syrups
  • Powders
  • Second Division Products
  • Generic Products

Achievements/ recognition :

  • Ortin has been certified as an ISO 9001: 2000 company by the internationally recognized Quality Management Certification Body, the National Quality Assurance, UK in pursuance of its focus towards Quality with its Policy to enhance customer satisfaction by providing Quality Pharmaceutical Formulations at optimum cost and maintain profitability through continual improvement of Quality Management Sytems and cGMP.
  • Ortin is honored as a registered Supplier of Drugs & Medicines with the most reputed Central, State & Quasi-Government Organizations & Institutions of our Country such as the Railways, Health Ministry, Defence, Posts & Telegraph, Electricity Hospitals, Transport Organizations, Research Institutions such as JIPMER, IICT etc.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.